WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark CUREMARK was filed as Word mark on 04/28/2021 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1600873 |
| Countries | 
|
| Base trademark |
No. 90322325,
November 16, 2020
|
| Application date | April 28, 2021 |
| Expiration date | April 28, 2031 |
Trademark owner
Suite 528 South
800 Westchester Avenue
US
800 Westchester Avenue
US
Trademark representatives
30 S. 17th Street
Philadelphia PA 19103
US
goods and services
05
Pharmaceutical preparations and substances for the
diagnosis, treatment and prevention of viral, bacterial,
fungal, parasitic metabolic, endocrine, hepatological,
respiratory, nervous system, neurological, gastrointestinal,
digestive, inflammatory, pulmonary, hormonal,
dermatological, psychiatric, addictive, behavioral,
infectious, addictive, musculoskeletal, cardiovascular,
ophthalmic, cardiopulmonary, genitourinary, sexual
dysfunction, oncological and immune system related diseases
and disorders; pharmaceutical preparations for the treatment
and prevention of influenza, coronaviruses, pancreatic
deficiencies, gastrointestinal disease, internal
malabsorption syndromes, autism, autism spectrum disorder,
attention deficit hyperactivity disorder and williams
syndrome; antibacterial, antiviral and antifungal
preparations for skin and wound healing; disinfectants and
antiseptics; antimicrobial cleansers for sanitation
purposes; medical assays for testing of bodily fluids and
tissues for testing of enzymes in humans; biological
preparations for medical testing; diagnostic preparations
for medical purposes; testing kits comprised of medical
diagnostic reagents and assays for testing enzymes and body
fluids for use in disease detection; medical diagnostic
reagents and assays for testing of enzymes and body fluids;
chemical preparations for medical testing; diagnostic
biomarker reagents for medical testing; all the foregoing
for the diagnosis and treatment of viral, bacterial, fungal,
parasitic metabolic, endocrine, hepatological, respiratory,
nervous system, neurological, gastrointestinal, digestive,
inflammatory, pulmonary, hormonal, dermatological,
psychiatric, addictive, behavioral, infectious, addictive,
musculoskeletal, cardiovascular, ophthalmic,
cardiopulmonary, genitourinary, sexual dysfunction,
oncological and immune system related diseases and
disorders
42
Providing medical and scientific research information in the
field of pharmaceuticals and clinical trials; medical and
pharmaceutical research; development of pharmaceuticals and
medical devices for others; providing temporary use of
non-downloadable computer software that allows users to make
determinations regarding neurological diseases, specifically
baseline staging, data gathering and monitoring of early,
middle and late stage neurological diseases; design and
development of medical assays for others; clinical research
and development of treatments for viral, bacterial, fungal,
parasitic metabolic, endocrine, hepatological, respiratory,
nervous system, neurological, gastrointestinal, digestive,
inflammatory, pulmonary, hormonal, dermatological,
psychiatric, addictive, behavioral, infectious, addictive,
musculoskeletal, cardiovascular, ophthalmic,
cardiopulmonary, genitourinary, sexual dysfunction,
oncological and immune system related diseases and
disorders; clinical research and development of treatments
for the treatment and prevention of influenza,
coronaviruses, pancreatic deficiencies, gastrointestinal
disease, internal malabsorption syndromes, autism, autism
spectrum disorder, attention deficit hyperactivity disorder
and williams syndrome; clinical research and development of
treatments for antibacterial, antiviral, and antifungal
preparations for skin and wound healing; clinical research
and development of disinfectants, antiseptics and
antimicrobial cleansers for sanitation purposes; medical and
scientific research services in the field of digestion and
detection of enzymes or biological substances in the body
44
Medical testing for diagnostic and treatment purposes;
medical consultations; medical testing for diagnostic
treatment purposes in the fields of viral, bacterial,
fungal, parasitic metabolic, endocrine, hepatological,
respiratory, nervous system, neurological, gastrointestinal,
digestive, inflammatory, pulmonary, hormonal,
dermatological, psychiatric, addictive, behavioral,
infectious, addictive, musculoskeletal, cardiovascular,
ophthalmic, cardiopulmonary, genitourinary, sexual
dysfunction, oncological and immune system related diseases
and disorders; medical testing for diagnostic treatment and
prevention of influenza, coronaviruses, pancreatic
deficiencies, gastrointestinal disease, internal
malabsorption syndromes, autism, autism spectrum disorder,
attention deficit hyperactivity disorder and williams
syndrome; medical diagnostic testing, monitoring and
reporting services; performing diagnosis of diseases
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 5, 2023 | 2023/1 Gaz | TH | Rejection |
| December 1, 2022 | 2022/48 Gaz | KR | Rejection |
| October 19, 2022 | 2022/42 Gaz | CA | Rejection |
| August 2, 2022 | 2022/33 Gaz | IL | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| July 13, 2022 | 2022/28 Gaz | BR | Rejection |
| July 7, 2022 | 2022/27 Gaz | MX | Rejection |
| July 1, 2022 | 2022/27 Gaz | LI | Rejection |
| June 28, 2022 | 2022/27 Gaz | EG | Rejection |
| June 2, 2022 | 2022/22 Gaz | CH | Rejection |
| April 21, 2022 | 2022/16 Gaz | JP | Rejection |
| April 21, 2022 | 2022/16 Gaz | CO | Rejection |
| February 28, 2022 | 2022/9 Gaz | TR | Rejection |
| February 17, 2022 | 2022/7 Gaz | GB | Rejection |
| January 7, 2022 | 2022/1 Gaz | SG | Rejection |
| January 6, 2022 | 2022/1 Gaz | NZ | Rejection |
| December 2, 2021 | 2021/50 Gaz | IL | Rejection |
| November 25, 2021 | 2021/47 Gaz | EM | Rejection |
| October 11, 2021 | 2021/41 Gaz | RU | Rejection |
| September 28, 2021 | 2021/39 Gaz | AU | Rejection |
| July 20, 2021 | 2021/30 Gaz | IN | Rejection |
| April 28, 2021 | 2021/25 Gaz | US | Registration |
ID: 141600873